RPG Life Sciences Ltd share price logo

RPG Life Share Price

NSE: RPGLIFE

BSE: 532983

Small Cap

Healthcare Sector

₹1921.50

+140.20

(+7.87%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

RPG Life Stock Performance

as on March 25, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹1,790.20
    ₹1,934.00
    downward going graph

    6.83%

    Downside

    0.65%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹1,733.00
    ₹2,725.00
    downward going graph

    9.81%

    Downside

    41.82%

    Upside

    downward going graph

RPG Life share price movements today

Previous Close
₹1,781.30
Open
₹1,790.20
Volume
14.70K
Upper Circuit
₹2,137.50
Lower Circuit
₹1,425.10
Day's Low - High
₹1,790.20 - ₹1,934.00
52 Week Low - High
₹1,733.00 - ₹2,725.00

RPG Life Historical Returns

1 Month Return
+ 0.64 %
3 Month Return
-18.67 %
1 Year Return
-15.62 %
3 Year Return
+ 172.59 %
5 Year Return
+ 429.27 %

RPG Life Fundamentals

as on March 25, 2026 at 4:01 pm IST

Market Cap

₹3,177.97 Cr

Return on Equity (ROE)

25.53

PE Ratio (TTM)

15.68

Return on capital employed (ROCE)

32.28

Industry PE ratio

40.67

Beta (LTM)

1.01

P/B Ratio

7.1

Dividend Yield

0

PEG Ratio

0.15

Quarterly Earnings Growth YOY

-36.64

EPS (TTM)

0

Sector

Pharmaceuticals

Book Value

0

Technical Analysis

Neutral

View Technical Analysis

RPG Life Stock Valuation

as on March 25, 2026 at 4:01 pm IST

RPG Life in the last 5 years

  • Overview

  • Trends

Lowest (0.00x)

September 29, 2025

Today (15.68x)

March 25, 2026

Industry (40.67x)

March 25, 2026

Highest (19.12x)

January 9, 2026

LowHigh

Today’s Price to Earnings Ratio: 15.68x

RPG Life Sciences Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of RPG Life with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
RPG Life Sciences Ltd image
RPG Life Sciences Ltd
NA3,177.9785.85%0.00183653
Kerala Ayurveda Ltd image
Kerala Ayurveda Ltd
NA234.7651.26%0.95-14125
Unjha Formulations Ltd image
Unjha Formulations Ltd
NA9.4029.39%0.00NA13
Desh Rakshak Aushdhalaya Ltd image
Desh Rakshak Aushdhalaya Ltd
NA15.39118.11%0.00NA6
Caplin Point Laboratories Ltd image
Caplin Point Laboratories Ltd
BUY12,128.4356.9%0.515411,937
See all

RPG Life Stock’s Investor Sentiment and Interest

Search interest for RPG Life Sciences Ltd Stock has decreased by -38% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-38% versus previous 30 day period

RPG Life Sciences Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Sales
172.71
143.09
168.92
181.68
180.03
Other Income
3.31
87.66
-3.19
15.76
3.41
Total Income
176.02
230.75
165.73
197.44
183.44
Expenses
123.55
90.3
125.03
142.65
148.69
Operating Profit
49.16
52.79
43.89
39.03
31.34
Operating Profit Margin %
28.46%
36.89%
25.98%
21.48%
17.41%
Profit Before Interest, Tax and Depreciation
52.47
140.45
40.7
54.79
34.75
Interest
0.12
0.18
0.13
0.12
0.25
Depreciation
5.46
5.37
5.14
5.22
5.38
Profit Before Tax
46.89
134.9
35.43
49.45
29.12
Tax Paid
11.96
17.55
9.14
12.6
6.99
Profit After Tax
34.93
117.35
26.29
36.85
22.13
Total Net profit including share of profit / Loss from associate company
34.93
117.35
26.29
36.85
22.13
EPS
21.12
70.96
15.9
22.28
13.38
Actual EPS
21.12
70.96
15.9
22.28
13.38
Adjusted EPS
21.12
70.96
15.9
22.28
13.38
Diluted EPS
21.12
-
-
22.28
13.38

RPG Life Sciences Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2025
Sales
653.43
Other Income
95.28
Total Income
748.71
Expenses
493.78
Operating Profit
159.65
Operating Profit Margin %
24.43%
Profit Before Interest, Tax and Depreciation
254.93
Interest
0.62
Depreciation
21.43
Profit Before Tax
232.88
Tax Paid
49.64
Profit After Tax
183.24
Total Net profit including share of profit / Loss from associate company
183.24
EPS
110.8
Actual EPS
110.8
Adjusted EPS
110.8
Diluted EPS
110.8

RPG Life Sciences Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
32.81
7.33
14.68
45.78
50.17
58.27
64.75
90.82
94.36
77.86
Cash Flow from Investing Activities
0.12
-30.06
-15.54
-19.02
-10.7
-7.96
-34.66
-105.81
-79.15
-41.8
Cash Flow from Financing Activities
-17.58
23.36
0.11
-26.5
-39.3
-10.49
-13.51
-17.12
-20.31
-27.08
Net Cash Flow
-0.02
0.63
-0.75
0.26
0.17
39.82
16.58
-32.11
-5.1
8.98

Mutual Funds that own RPG Life Stock

Check out the Mutual Funds with significant holdings in RPG Life.

RPG Life Corporate Actions

View detailed summary of the earnings and dividend history of RPG Life.

  • RPG Life Sciences Ltd Earnings Results

    RPG Life Sciences Ltd’s net profit fell -36.64% since last year same period to ₹22.13Cr in the Q3 2025-2026. On a quarterly growth basis, RPG Life Sciences Ltd has generated -39.95% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • RPG Life Sciences Ltd Dividends April,2025

    In the quarter ending March 2025, RPG Life Sciences Ltd has declared dividend of ₹20.00 per share on 28 Apr 2025 - translating a dividend yield of 2.08%.

    Read More about Dividends

Indices Featuring RPG Life Stock

Check stock indices that include RPG Life.

BSE Healthcare

₹42,739.33

2.06 (▲861.80%)

Insights on RPG Life Sciences Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, RPGLIFE stock has moved up by 5.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 33.5% return, outperforming this stock by 49.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 179.8% return, outperforming this stock by 7.2%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 72.95% of holdings in Dec 2025 quarter

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 3.20% to 0.04% in Dec 2025 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 19.24% to 19.01% in Dec 2025 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 1.11% to 1.00% in Dec 2025 quarter

About RPG Life Sciences Ltd

RPG Life Sciences Ltd (formerly Searle India Ltd) began operations in 1968 as a joint venture with GD Searle USA. After 1993 GD Searle withdrew and sold its holdings to the RPG Group. The company is involved in the manufacturing and marketing of Formulations Finished Dosage Forms and Active Pharmaceutical Ingredients APIs. It has research and development facilities which are internationally compliant, such as Biotech RD API RD and Formulations RD, as well as TGA Aus and MHRA UK approved facilities in Thane in Maharashtra and Ankleshwar in Gujarat. In 2008 the equity shares of the company were listed on BSE and NSE, and in 2009-2010 the company increased the production capacity of Bulk Drugs and Chemicals from 62 to 71 tonnes. They launched an oncology drug, Exemestane, as well as Nufex Beta QugylO Immunotec. Adding to it, during the year 2009-2010, 11 new products across a range of therapeutic segments were launched, such as Demator Sizomax Mela Exinia and Mofetyl S, and they also launched a new immunosuppressant product Sirolimus during the same year. New divisions in the highly growing chronic segments Cardiology, Diabetic, Neurology-Psychiatry, Oncology were also launched. The Company sold its Biotech Unit located at Ankleshwar to M/s. Intas Pharmaceuticals Limited as a going concern in 2016-2017 and acquired 7 brands from Sun Pharmaceuticals Limited the same year. In 2017-2018, the Company launched two new brands Darbepoetin and RituximabXMAB in the post-transplant care space. It also launched a new product TJAKi JAK Inhibitor in the immunosuppressant range of products in Rheumatology and Gastroenterology in FY21, and Azoran 75 mg new line extension was also launched in 2021. Naprosyn and AldactoneF were launched in FY22.

Revenue: ₹180.03Cr as on December 2025 (Q3 FY26)
Net Profit: ₹22.13Cr as on December 2025 (Q3 FY26)
Listing date: 10 Jun, 2008
Chairperson Name: H V Goenka
OrganisationRPG Life Sciences Ltd
IndustryPharmaceuticals
CEOH V Goenka
E-voting on sharesClick here to vote

FAQs

What is RPG Life share price today?

RPG Life share price today stands at ₹1921.5 as on at the close of the market. RPG Life share today touched a day high of ₹1934 and a low of ₹1790.2.

What is the 52 week high and 52 week low range for RPG Life share?

RPG Life touched a 52 week high of ₹2725 and a 52 week low of ₹1733. RPG Life share price today i.e. is closed at ₹1921.5, which is -29.49% down from its 52 week high and 10.88% up from its 52 week low.

What is RPG Life's market capitalisation today?

RPG Life market capitalisation is ₹3,177.97 Cr as on .

How to buy RPG Life shares?

To buy RPG Life shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for RPGLIFE or RPG Life Sciences Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in RPG Life shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is RPG Life trading volume today?

RPG Life trading volume is 14.70K as on . This means that 14.70K shares of RPG Life were bought and sold on the stock market during today's trading session.